Less nephrotoxicity of paclitaxel and ifosfamide plus nedaplatin for refractory or relapsed germ cell tumors in patients with impaired renal function
Sign Up to like & getrecommendations! Published in 2019 at "International Journal of Urology"
DOI: 10.1111/iju.14147
Abstract: To determine the safety and efficacy of the combined regimen of paclitaxel and ifosfamide plus nedaplatin for patients with refractory or relapsed germ cell tumors and impaired renal function. read more here.
Keywords: plus nedaplatin; refractory relapsed; paclitaxel ifosfamide; germ cell ... See more keywords